Company profile: Cresilon
1.1 - Company Overview
Company description
- Provider of plant-based hemostatic gel solutions for trauma care, offering VETIGEL for veterinary use and Cresilon Hemostatic Gel (CHG) for human use. VETIGEL is biocompatible and stops bleeding in seconds; both gels work quickly without the need for manual pressure.
Products and services
- Cresilon Hemostatic Gel (CHG): Plant-based hemostatic gel for human use that quickly stops bleeding without manual pressure, engineered for trauma care
- VETIGEL: Plant-based, biocompatible hemostatic gel for veterinary use that stops bleeding in seconds without manual pressure, constructed to achieve rapid hemostasis
- Trauma Care Products Production and Marketing: Cresilon produces and markets plant-based hemostatic products for trauma care, supplying rapid bleeding control without manual pressure across human and veterinary applications.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cresilon
Tacere Therapeutics
HQ: United States
Website
- Description: Provider of novel therapeutics for serious infectious diseases, including Hepatitis C (HCV), leveraging RNA interference (RNAi), gene medicine, and novel biologicals, with proprietary expertise in identifying and developing RNAi therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tacere Therapeutics company profile →
Sirnaomics
HQ: United States
Website
- Description: Provider of RNA interference-based therapeutics and delivery platforms. Develops STP705, an siRNA targeting TGF-β1 and COX-2 for non-melanoma skin cancer, cholangiocarcinoma, and hypertrophic scars; RNAi prophylactics and therapeutics for severe acute respiratory infection caused by 2019-nCoV; and delivery technologies including a polypeptide nanoparticle platform for mRNA vaccines/therapeutics and a GalNAc platform for liver-targeted RNAi.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sirnaomics company profile →
Shocking Technologies
HQ: United States
Website
- Description: Provider of Voltage Switchable Dielectric (VSD) materials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Shocking Technologies company profile →
Thermexit
HQ: United States
Website
- Description: Provider of high-end thermal interface gap filler pads delivering thermal management solutions, with technology derived from years of government-funded research in advanced materials, including the application of carbon nanotubes in electrochemical systems, as well as dispersion, compounding, and coating.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Thermexit company profile →
NanoSteel
HQ: United States
Website
- Description: Provider of advanced, patented nanostructured steel materials, specializing in the design and commercialization of proprietary alloys for use as sheet steel in automotive light-weighting applications, delivering exceptional mechanical properties derived from nano-scale microstructures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoSteel company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cresilon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cresilon
2.2 - Growth funds investing in similar companies to Cresilon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cresilon
4.2 - Public trading comparable groups for Cresilon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →